| 1 |
中国医疗保健国际交流促进会胃食管反流多学科分会. 中国胃食管反流病多学科诊疗共识[J/OL]. 中华胃食管反流病电子杂志, 2020, 7(1): 1-28.
|
| 2 |
Labenz J, Labenz G, Stephan D, et al. [Insufficient symptom control under long-term treatment with PPI in GERD-fact or fiction?[J]. MMW Fortschr Med, 2016, 158 Suppl 4: 7-11.
|
| 3 |
Zahid A, Li B, Kombe AJK, et al. Pharmacological inhibitors of the NLRP3 inflammasome[J]. Front Immunol, 2019, 10: 2538.
|
| 4 |
Zhen Y, Zhang H. NLRP3 Inflammasome and inflammatory bowel disease[J]. Front Immunol, 2019, 10: 276.
|
| 5 |
Shao BZ, Xu ZQ, Han BZ, et al. NLRP3 inflammasome and its inhibitors: a review[J]. Front Pharmacol, 2015, 6: 262.
|
| 6 |
Clarrett DM, Hachem C. Gastroesophageal reflux disease (GERD)[J]. Mo Med, 2018, 115(3): 214-218.
|
| 7 |
Ustaoglu A., et al., Mucosal pathogenesis in gastro-esophageal reflux disease[J]. Neurogastroenterol Motil, 2020, 32(12): e14022.
|
| 8 |
Richter JE, Rubenstein JH. Presentation and epidemiology of gastroesophageal reflux disease[J]. Gastroenterology, 2018, 154(2): 267-276.
|
| 9 |
Salvo Romero E, Alonso Cotoner C, Pardo Camacho C, et al. The intestinal barrier function and its involvement in digestive disease[J]. Rev Esp Enferm Dig, 2015, 107(11): 686-696.
|
| 10 |
Sharma VK. Role of endoscopy in GERD[J]. Gastroenterol Clin North Am, 2014, 43(1): 39-46.
|
| 11 |
No authors. Gastroesophageal reflux disease: pathophysiology, diagnosis, and treatment[J]. Gastroenterol Nurs, 2019, 42(1): 20-28.
|
| 12 |
Yu HX, Han CS, Xue JR, et al. Esophageal hiatal hernia: risk, diagnosis and management[J]. Expert Rev Gastroenterol Hepatol, 2018, 12(4): 319-329.
|
| 13 |
Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American gastroenterological association[J]. Gastroenterology, 2017, 152(4): 706-715.
|
| 14 |
Kaminski MF, Ermer T, Canavan M, et al. Evaluation of gastroesophageal reflux disease and hiatal hernia as risk factors for lobectomy complications[J]. JTCVS Open, 2022,11:327-345.
|
| 15 |
张成, 汪忠镐, 李俊生, 等. 2013年美国胃肠内镜外科医师协会食管裂孔疝治疗指南解读(二)[J/OL]. 中华胃食管反流病电子杂志, 2015, 2(2): 2.
|
| 16 |
Chan EG, Sarkaria IS, Luketich JD, et al. Laparoscopic approach to paraesophageal hernia repair[J]. Thorac Surg Clin, 2019, 29(4): 395-403.
|
| 17 |
Rossetti G, Limongelli P, Cimmino M, et al. Outcome of medical and surgical therapy of GERD: predictive role of quality of life scores and instrumental evaluation[J]. Int J Surg, 2014, 12 Suppl 1: S112-S116.
|
| 18 |
Galmiche JP, Hatlebakk J, Attwood S, et al. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial[J]. JAMA, 2011, 305(19): 1969-1977.
|
| 19 |
Fiocca R, Mastracci L, Attwood SE, et al. Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial[J]. Aliment Pharmacol Ther, 2012, 36(10): 959-971.
|
| 20 |
买买提·依斯热依力, 阿孜古丽·阿力木江, 吾布力卡斯木·吾拉木, 等. Nox-4在慢性束缚应激致小鼠胃黏膜炎症损伤发生中的作用[J]. 中华行为医学与脑科学杂志, 2019, 28(4): 316-321.
|
| 21 |
Zhen Y, Zhang H. NLRP3 inflammasome and inflammatory bowel disease[J]. Front Immunol, 2019, 10: 276.
|
| 22 |
阿布拉江•米吉提, 买买提•依斯热依力, 艾克拜尔•艾力, 等. 丙二醛在胃食管反流病食管黏膜炎症发生中的表达及作用机制[J]. 中国医师杂志, 2019, 21(7): 997-1001, 1006.
|
| 23 |
Yan Y, Jiang W, Liu L, et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome[J]. Cell, 2015, 160(1-2): 62-73.
|
| 24 |
Patel D, Vaezi MF. Normal esophageal physiology and laryngopharyngeal reflux[J]. Otolaryngol Clin North Am, 2013, 46(6): 1023-1041.
|
| 25 |
Souza RF, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury[J]. Gastroenterology, 2009, 137(5): 1776-1784.
|
| 26 |
Isomoto H, Wang A, Mizuta Y, et al. Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis[J]. Am J Gastroenterol, 2003, 98(3): 551-556.
|
| 27 |
阿孜古丽·阿力木江, 买买提·依斯热依力, 王婧, 等. 心理应激对雌性小鼠胃泌素、雌激素及其胃食管炎症因子的影响[J/OL]. 中华胃食管反流病电子杂志, 2020, 7(4): 207-212.
|
| 28 |
Aziz Q, Fass R, Gyawali CP, et al. Functional esophageal disorders[J]. Gastroenterology, 2016, 15: S0016-5085(16)00178-5.
|
| 29 |
Yu X, Hu Y, Ru F, et al. TRPM8 function and expression in vagal sensory neurons and afferent nerves innervating guinea pig esophagus[J]. Am J Physiol Gastrointest Liver Physiol, 2015, 308(6): G489-G496.
|
| 30 |
Banovcin P, Duricek M, Zatko T, et al. The infusion of menthol into the esophagus evokes cold sensations in healthy subjects but induces heartburn in patients with gastroesophageal reflux disease (GERD)[J]. Dis Esophagus, 2019. 32(11): doz038.
|
| 31 |
Woodland P, Aktar R, Mthunzi E, et al. Distinct afferent innervation patterns within the human proximal and distal esophageal mucosa[J]. Am J Physiol Gastrointest Liver Physiol, 2015, 308(6): G525-G531.
|
| 32 |
St-Jacques B, Ma W. Peripheral prostaglandin E2 prolongs the sensitization of nociceptive dorsal root ganglion neurons possibly by facilitating the synthesis and anterograde axonal trafficking of EP4 receptors[J]. Exp Neurol, 2014, 261: 354-366.
|
| 33 |
Bujak JK, Kosmala D, Szopa IM, et al. Inflammation, cancer and immunity-implication of TRPV1 channel[J]. Front Oncol, 2019, 9: 1087.
|
| 34 |
Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling[J]. Nat Rev Immunol, 2016, 16(7): 407-420.
|
| 35 |
蒋丹露, 刘阳阳, 孙如愚, 等, NLRP3炎症小体介导的炎症相关疾病研究进展[J]. 生命科学, 2017, 29(9): 898-907.
|
| 36 |
Qian H, Li Q, Shi W. Hyperbaric oxygen alleviates the activation of NLRP3 inflammasomes in traumatic brain injury[J]. Mol Med Rep, 2017, 16(4): 3922-3928.
|
| 37 |
周永婷, 叶菜英, 朱蕾. NLRP 3炎性小体激活调控机制及抑制剂研究新进展[J]. 基础医学与临床, 2020, 40(8): 1113-1118.
|
| 38 |
Mao L, Kitani A, Similuk M, et al. Loss-of-function CARD8 mutation causes NLRP3 inflammasome activation and Crohn's disease[J]. J Clin Invest, 2018, 128(5): 1793-1806.
|
| 39 |
Dinarello CA, Donath MY, Mandrup-Poulsen T. Role of IL-1beta in type 2 diabetes[J]. Curr Opin Endocrinol Diabetes Obes, 2010, 17(4): 314-321.
|
| 40 |
Iyer SS, He Q, Janczy JR, et al. Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation[J]. Immunity, 2013, 39(2): 311-323.
|
| 41 |
龚勇珍, 孙少卫, 廖端芳. 细胞炎症反应与脂质代谢的相互作用及调节简[J]. 中国动脉硬化杂志, 2017, 25(6):7.
|
| 42 |
Goldberg EL, Asher JL, Molony RD, et al. β-hydroxybutyrate deactivates neutrophil NLRP3 Inflammasome to relieve gout flares[J]. Cell Rep, 2017, 18(9): 2077-2087.
|